Anixa Biosciences Inc (ANIX) › Operating IncomeAnixa Biosciences Inc (ANIX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.25M2011: -$5.03M2012: -$4.13M2013: -$7.92M2014: -$5.04M2015: -$944.8K2016: -$4.51M2017: -$6.08M2018: -$14.29M2019: -$11.89M2020: -$9.98M2021: -$13.14M2022: -$13.88M2023: -$11.01M2024: -$13.83M2025: -$11.70M-$11.70M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$11.70M+15.4%2024-$13.83M-25.6%2023-$11.01M+20.6%2022-$13.88M-5.6%2021-$13.14M-31.6%2020-$9.98M+16.1%2019-$11.89M+16.8%2018-$14.29M-135.2%2017-$6.08M-34.7%2016-$4.51M-377.3%2015-$944.8K+81.3%2014-$5.04M+36.3%2013-$7.92M-91.5%2012-$4.13M+17.8%2011-$5.03M+4.2%2010-$5.25M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share